BackDynavax Technologies Overview

Dynavax Technologies Receivables

Track Dynavax Technologies's receivables ($73M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$73.32M
2.60% YoYΔ $-1.96M vs prior year quarter

Peer trimmed avg / median

Loading

Dynavax Technologies Receivables History

Loading

Dynavax Technologies vs. peers: Receivables Comparison

Loading

Dynavax Technologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Dynavax Technologies (DVAX) FAQ

As of the most recent data (September 2025), DVAX shows a receivables of $73M. That compares with $75M in the prior-year period — down 2.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DVAX's receivables is now $73M (was $75M) — a 2.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Dynavax Technologies is outperforming or lagging.

Tracking DVAX's receivables over time shows whether Dynavax Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $73M That compares with $75M in the prior-year period — down 2.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Dynavax Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $73M) with ownership activity and broader fundamentals.

Dynavax Technologies's receivables is $73M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.